Search results
Showing 106 to 108 of 108 results for melanoma
Evidence-based recommendations on bortezomib (Velcade) for treating multiple myeloma before chemotherapy and stem cell transplant in adults.
Early Cancer Diagnosis: 75% of cases diagnosed at stage 1 or 2 by 2028.
Around 1,500 people aged 12 years and over with melanoma are set to benefit from pembrolizumab, a drug that reduces the chance of it returning.